The proposed bill, known as the Defense of Drug Delivery Act, aims to regulate the distribution of drugs under the federal 340B drug pricing program in Kansas. It prohibits manufacturers, third-party logistics providers, and repackagers from denying or restricting the delivery of 340B drugs to covered entities, unless such actions are mandated by federal or state law. Additionally, manufacturers cannot require covered entities to submit health information or other data as a condition for receiving these drugs. The bill establishes a framework for enforcement, allowing the Kansas Attorney General to impose civil penalties for violations and to create a dedicated fund for administering the act.

Key provisions include the establishment of the Defense of Drug Delivery Fund, which will be financed by fines collected for violations, and the authority granted to the Attorney General to investigate complaints and impose penalties. The bill also clarifies that limited distribution requirements under federal law do not constitute a violation of this act, and it ensures that the act does not conflict with existing federal laws. Overall, the legislation seeks to protect the integrity of the 340B drug pricing program and ensure that covered entities can access necessary medications without undue interference from manufacturers.